Limits...
Pancreaticoduodenectomy for secondary periampullary cancer following extrahepatic bile duct cancer resection.

Kim DH, Choi DW, Choi SH, Heo JS - Ann Surg Treat Res (2014)

Bottom Line: Metachronous tumor was confirmed by periampullary pathology in all cases.There were no perioperative deaths.Median survival after PD was 44.6 months (range, 8.5-120.5 months).

View Article: PubMed Central - PubMed

Affiliation: Department of Surgery, Dankook University Hospital, Cheonan, Korea.

ABSTRACT

Purpose: This study addressed the feasibility and effect of surgical treatment of metachronous periampullary carcinoma after resection of the primary extrahepatic bile duct cancer. The performance of this secondary curative surgery is not well-documented.

Methods: We reviewed, retrospectively, the medical records of 10 patients who underwent pancreaticoduodenectomy (PD) for secondary periampullary cancer following extrahepatic bileduct cancer resection from 1995 to 2011.

Results: The mean age of the 10 patients at the second operation was 61 years (range, 45-70 years). The primary cancers were 7 hilar cholangiocarcinomas, 2 middle common bile duct cancers, and one cystic duct cancer. The secondary cancers were 8 distal common bile duct cancers and 2 carcinomas of the ampulla of Vater. The second operations were 6 Whipple procedures and 4 pylorus-preserving pancreaticoduodenectomies. The mean interval between primary treatment and metachronous periampullary cancer was 20.6 months (range, 3.4-36.6 months). The distal resection margin after primary resection was positive for high grade dysplasia in one patient. Metachronous tumor was confirmed by periampullary pathology in all cases. Four of the 10 patients had delayed gastric emptying (n = 2) or pancreatic fistula (n = 2) after reoperation. There were no perioperative deaths. Median survival after PD was 44.6 months (range, 8.5-120.5 months).

Conclusion: Based on the postoperative survival rate, PD may provide an acceptable protocol for resection in patients with metachronous periampullary cancer after resection of the extrahepatic bile duct cancer.

No MeSH data available.


Related in: MedlinePlus

Overall survival rates (A) after extrahepatic bile duct resection and (B) after pancreaticoduodenectomy for secondary periampullary cancer.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4127899&req=5

Figure 1: Overall survival rates (A) after extrahepatic bile duct resection and (B) after pancreaticoduodenectomy for secondary periampullary cancer.

Mentions: Median survival after EHBD cancer resection including the survival period after PD was 56.1 months (range, 18.6-152.7 months). Median survival after PD was 44.6 months (range, 8.5-120.5 months) (Fig. 1).


Pancreaticoduodenectomy for secondary periampullary cancer following extrahepatic bile duct cancer resection.

Kim DH, Choi DW, Choi SH, Heo JS - Ann Surg Treat Res (2014)

Overall survival rates (A) after extrahepatic bile duct resection and (B) after pancreaticoduodenectomy for secondary periampullary cancer.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4127899&req=5

Figure 1: Overall survival rates (A) after extrahepatic bile duct resection and (B) after pancreaticoduodenectomy for secondary periampullary cancer.
Mentions: Median survival after EHBD cancer resection including the survival period after PD was 56.1 months (range, 18.6-152.7 months). Median survival after PD was 44.6 months (range, 8.5-120.5 months) (Fig. 1).

Bottom Line: Metachronous tumor was confirmed by periampullary pathology in all cases.There were no perioperative deaths.Median survival after PD was 44.6 months (range, 8.5-120.5 months).

View Article: PubMed Central - PubMed

Affiliation: Department of Surgery, Dankook University Hospital, Cheonan, Korea.

ABSTRACT

Purpose: This study addressed the feasibility and effect of surgical treatment of metachronous periampullary carcinoma after resection of the primary extrahepatic bile duct cancer. The performance of this secondary curative surgery is not well-documented.

Methods: We reviewed, retrospectively, the medical records of 10 patients who underwent pancreaticoduodenectomy (PD) for secondary periampullary cancer following extrahepatic bileduct cancer resection from 1995 to 2011.

Results: The mean age of the 10 patients at the second operation was 61 years (range, 45-70 years). The primary cancers were 7 hilar cholangiocarcinomas, 2 middle common bile duct cancers, and one cystic duct cancer. The secondary cancers were 8 distal common bile duct cancers and 2 carcinomas of the ampulla of Vater. The second operations were 6 Whipple procedures and 4 pylorus-preserving pancreaticoduodenectomies. The mean interval between primary treatment and metachronous periampullary cancer was 20.6 months (range, 3.4-36.6 months). The distal resection margin after primary resection was positive for high grade dysplasia in one patient. Metachronous tumor was confirmed by periampullary pathology in all cases. Four of the 10 patients had delayed gastric emptying (n = 2) or pancreatic fistula (n = 2) after reoperation. There were no perioperative deaths. Median survival after PD was 44.6 months (range, 8.5-120.5 months).

Conclusion: Based on the postoperative survival rate, PD may provide an acceptable protocol for resection in patients with metachronous periampullary cancer after resection of the extrahepatic bile duct cancer.

No MeSH data available.


Related in: MedlinePlus